|
|
||||||||
Articles |
1
Abteilung für Innere Medizin und Poliklinik m.S. Hämatologie und Onkologie, Campus Virchow-Klinikum, Medizinische Fakultät Charité der Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
a Author for correspondence. Fax 49-30-45053929; e-mail
christian.schmidt{at}charite.de.
| Abstract |
|---|
|
|
|---|
Methods: For quantification of target and reference sequences, we used two fluorescent probes in one reaction vessel on an ABI PRISM 7700 SDS instrument. Fluorescent probes were labeled with either 6-carboxy-fluorescein or hexachloro-6-carboxy-fluorescein as reporter dye and 4-(4'-dimethylaminophenylazo)benzoic acid (DABCYL) as a dark quencher fluorophore. To test the sensitivity and specificity of this assay, serial dilutions of reference and target templates were analyzed in one PCR reaction. In the presence of 10 ß-actin molecules as control templates, 105 bcr/abl molecules were amplified, and 105 ß-actin molecules were amplified in the presence of 10 bcr/abl copies. We also performed single and duplex measurements on samples from five patients with documented Philadelphia chromosome-positive chronic myelogenous leukemia disease courses (72 samples) and three with minor bcr/abl+ acute myelogenous leukemias (26 samples).
Results: For M-bcr/abl duplex RT-PCR, the correlation coefficient (r) for starting template amounts and threshold cycle values was 0.99; for m-bcr/abl, r = 0.96, indicating a precise log-linear relation for 10105 copies/100 ng of cDNA. In the same PCR reactions, r = 0.99 for ß-actin (coamplified with M-bcr/abl or m-bcr/abl) for 103107 copies/100 ng cDNA. The linear correlation coefficient for single and duplex measurements was 0.98 for M- and m-bcr/abl in patient samples.
Conclusions: DABCYL can be used as dark quencher fluorophore in real-time fluorescence PCR. The duplex fluorescence RT-PCR assay for bcr/abl and ß-actin transcripts allows monitoring of bcr/abl+ leukemias.
| Introduction |
|---|
|
|
|---|
However, for real-time fluorescent PCR as for conventional PCR, a control reaction is necessary to correct quantitative results with respect to the total amount of amplifiable material in the investigated sample (3). This is of special importance in reverse transcription-PCR (RT-PCR)1 because RNA preparation and reverse transcription reactions usually produce various quantities of cDNA.
A control can be performed by quantification of an external standard in a separate assay. Nevertheless, because this requires a second reaction and each PCR has its own kinetics, internal standardization is thought to be more reliable (4). In fluorescence PCR, this can be done only if the simultaneously used reporter dye of the control reaction signal can be quantitatively distinguished from the fluorescence generated by target-specific probes.
To date, quantification of an internal standard with the ABI PRISM 7700 SDS instrument has been limited to fluorescent quencher fluorophores, such as 6-carboxy-tetramethylrhodamine (TAMRA), that themselves produce substantial fluorescence at wavelengths close to those of the reporter dyes. Thus, depending on the reporter fluorophore used, TAMRA can produce measurable fluorescence signals within the reporter dye channels, which would again decrease the specificity and sensitivity of the assays. Moreover, if TAMRA is used as a quencher dye, it blocks a broad wavelength range that could be otherwise be used for incorporation of additional reporter dyes (5). This is of relevance for future development of multicolor-multiplex real-time fluorescence PCR techniques.
In an attempt to facilitate development of such techniques, we investigated whether 4-(4'-dimethylaminophenylazo)benzoic acid (DABCYL), a quencher dye with no or minimal autofluorescence within the wavelengths measured in the ABI PRISM 7700 SDS, can be used for this purpose. To demonstrate the clinical applicability of this approach, we quantified bcr/abl fusion transcripts in two cases of Philadelphia chromosome-positive leukemias by single and duplex RT-PCR.
| Materials and Methods |
|---|
|
|
|---|
blood samples
The total RNA of peripheral blood samples was extracted by a
guanidinium isothiocyanate-acid phenol procedure (6), and
2000 ng of the extracted RNA was reverse-transcribed into cDNA with
random hexamer primers. cDNA samples were stored at -20 °C until
assayed.
design of fluorescent probes
The fluorescent probes for M-bcr/abl and m-bcr/abl were designed
to hybridize within the abl terminus of the amplicons as published
previously (7). Probes were covalently labeled with
hexachloro-6-carboxy-fluorescein (HEX) at the 5' end, representing the
reporter dye, and DABCYL was incorporated as amidite after deprotection
at the 3' end of the probe sequences. To prevent probe elongation, a
phosphate group was attached. Probes were purified by HPLC. ß-actin
was used as reference gene, and fluorescent probe and primer sequences
were as published elsewhere (8). The ß-actin probe was
labeled at the 5' end with 6-carboxy-fluorescein (FAM) phosphoramidite
and at the 3' terminus with DABCYL. To prevent probe extension,
phosphate groups were attached to the 3' ends of all probes (TIB
Molbiol).
primers and pcr conditions
PCR of bcr/abl was performed using a single pair of primers
located in exon 1 (m-bcr/abl: 5'-CAgATCTggCCCAACgATg-3') or exon 2
(M-bcr/abl: 5'-CTgACCAACTCgTgTgTgAAAC-3') of bcr and in exon 3
(5'-CCCCATTgTgATT-ATAgCCTAAgA-3') of abl. Thus, all four M-bcr/abl
fusions could be amplified with a single set of oligonucleotides. An
ABI PRISM 7700 Sequence Detector (PE Applied Biosystems) was used for
PCR reactions and fluorescence measurements.
The 50-µL PCR reaction mixture for single measurements of bcr/abl or ß-actin contained 5 µL of 10x PCR buffer, 4.5 mM MgCl2, 0.8 mM dNTPs (Life Technologies), 1 µM 5,6-carboxy-x-rhodamine, 0.8 µL of Tris-EDTA buffer (pH 8.0), 0.5 µM each primer, 1 µL of probe, 1.25 U of Taq DNA polymerase (Platinum DNA polymerase; Life Technologies), and 100 ng of sample cDNA. PCR amplification began with a 5-min denaturation step at 95 °C, followed by 45 cycles of denaturation at 95 °C for 30 s and annealing/extension at 63 °C (m-bcr/abl), 65 °C (M-bcr/abl), or 67 °C (ß-actin) for 1 min.
Duplex PCR measurements were performed with a few modifications. The PCR reaction mixture included two primer sets, two fluorescence probes, and sample cDNA in the same concentrations used in the single assay, except for ß-actin primers, which were limited to 0.05 µM each. Duplex real-time PCR was performed for 5 min at 95 °C and 45 cycles of 95 °C for 30 s and 63 °C (m-bcr/abl and ß-actin) or 65 °C (M-bcr/abl and ß-actin) for 1 min.
data analysis
Statistical analyses were performed using Excel software
(Microsoft).
| Results |
|---|
|
|
|---|
|
To test the sensitivity and specificity of this assay, we performed
PCRs in which the concentration of one template was orders of magnitude
higher than the concentration of the other template. In the
presence of 10 control templates, 105 bcr/abl
molecules were amplified, and in the presence of 10 bcr/abl copies,
105 ß-actin molecules were amplified. Fig. 2
illustrates calibration curves obtained by plotting the initial
number of target molecules in the dilution series against the
respective threshold cycle. The threshold cycle is the cycle
number at which the fluorescence of a given sample becomes
significantly different from the baseline signal, i.e., 10 SD above
background fluorescence during the first 15 PCR cycles.
For M-bcr/abl duplex RT-PCR, the correlation coefficient (r)
was 0.99, for m-bcr/abl, r = 0.96, indicating a precise
log-linear relationship at template concentrations of
10105 copies/100 ng of cDNA. In the respective
PCR reactions, r = 0.99 for ß-actin (coamplified with
M-bcr/abl or m-bcr/abl) for
103107 copies/100 ng of
cDNA. Ethidium bromide staining of conventional agarose gel
electrophoresis after amplification of b2a3/ß-actin and
e1a2/ß-actin templates in a duplex fluorescence RT-PCR is
shown in Fig. 2, B and D
. As shown in Fig. 2, A and D
, visible
gel bands correlate well with the obtained quantitative PCR results. To
compare absolute amounts of template molecules obtained by single and
duplex measurements, we performed correlation studies using
samples from five patients with Philadelphia chromosome-positive
chronic myelogenous leukemia (CML; n = 72) and three patients with
m-bcr/abl+ acute myelogenous leukemia (AML;
n = 26). As can be seen from Fig. 3
, the ratios (target transcript copies divided by reference
transcript copies) correlated well (r = 0.98 for
M-bcr/abl and r = 0.98 for m-bcr/abl).
|
|
To evaluate the clinical applicability of the developed assay, we
retrospectively investigated two disease courses of a Philadelphia
chromosome-positive CML and a biphenotypic
bcr/abl+ AML by real-time PCR, amplifying target
and reference gene either separately (single) or simultaneously
(duplex). Fig. 4A
shows bcr/abl:ß-actin transcript ratio for a CML patient in
chronic phase who underwent matched unrelated donor bone marrow
transplantation. After 2 months, he underwent a second
allogeneic bone marrow transplantation and exhibited a marked decrease
of bcr/abl fusion transcripts. Fig. 4B
illustrates bcr/abl transcript
kinetics in a Philadelphia chromosome-positive AML. The observed
increase of bcr/abl mRNA was clearly associated with progressive
disease and, subsequently, death of the patient.
|
| Discussion |
|---|
|
|
|---|
In conclusion, simultaneous quantification of two sequences in one tube can be performed using DABCYL as a dark quencher dye. This may facilitate future development of quantitative multicolor real-time PCR techniques.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 Nonstandard abbreviations: RT-PCR, reverse transcription-PCR; TAMRA, 6-carboxy-tetramethylrhodamine; DABCYL, 4-(4'-dimethylaminophenylazo)benzoic acid; M- and m-bcr/abl, major and minor bcr/abl, respectively; HEX, hexachloro-6-carboxy-fluorescein; FAM, 6-carboxy-fluorescein; CML, chronic myelogenous leukemia; and AML, acute myelogenous leukemia. ![]()
| References |
|---|
|
|
|---|
The following articles in journals at HighWire Press have cited this article:
![]() |
M. B. Grace, C. B. McLeland, S. J. Gagliardi, J. M. Smith, W. E. Jackson III, and W. F. Blakely Development and Assessment of a Quantitative Reverse Transcription-PCR Assay for Simultaneous Measurement of Four Amplicons Clin. Chem., September 1, 2003; 49(9): 1467 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sanchez-Vega, F. Vega, L. J. Medeiros, M. S. Lee, and R. Luthra Quantification of bcl-2/JH Fusion Sequences and a Control Gene by Multiplex Real-Time PCR Coupled with Automated Amplicon Sizing by Capillary Electrophoresis J. Mol. Diagn., November 1, 2002; 4(4): 223 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nowakowski-Gashaw, P. M. Mrozikiewicz, I. Roots, and J. Brockmoller Rapid Quantification of CYP3A4 Expression in Human Leukocytes by Real-Time Reverse Transcription-PCR Clin. Chem., February 1, 2002; 48(2): 366 - 370. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |